Latest Upgrades And Downgrades from Yahoo Finance 2025-03-20
| Grade Date | Ticker | To Grade | From Grade | Action | Firm | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-20 | ABSI | Buy | Buy | reit | Guggenheim | 4 | 5 | 0 | 0 | 0 |
| 2025-03-20 | ACVA | Overweight | Neutral | up | Piper Sandler | 7 | 5 | 2 | 0 | 0 |
| 2025-03-20 | ADBE | Market Perform | Market Perform | reit | Citizens Capital Markets | 9 | 18 | 11 | 1 | 1 |
| 2025-03-20 | AEE | Equal-Weight | Equal-Weight | main | Morgan Stanley | 1 | 7 | 7 | 0 | 2 |
| 2025-03-20 | AEP | Overweight | Overweight | main | Morgan Stanley | 3 | 3 | 14 | 1 | 0 |
| 2025-03-20 | ALK | Buy | Buy | main | UBS | 5 | 10 | 1 | 0 | 0 |
| 2025-03-20 | AMTM | Neutral | init | Goldman Sachs | 1 | 1 | 3 | 0 | 0 | |
| 2025-03-20 | AMZN | Market Outperform | Market Outperform | reit | Citizens Capital Markets | 18 | 46 | 3 | 0 | 0 |
| 2025-03-20 | ASO | Outperform | Outperform | main | Telsey Advisory Group | 1 | 8 | 10 | 0 | 0 |
| 2025-03-20 | BE | Overweight | Overweight | main | Morgan Stanley | 5 | 8 | 13 | 0 | 2 |
| 2025-03-20 | BLMN | Neutral | Neutral | main | JP Morgan | 0 | 1 | 10 | 0 | 2 |
| 2025-03-20 | BRZE | Outperform | Outperform | main | Raymond James | 8 | 10 | 1 | 0 | 0 |
| 2025-03-20 | BWA | Overweight | Overweight | main | Piper Sandler | 7 | 5 | 6 | 0 | 0 |
| 2025-03-20 | CAKE | Underweight | Underweight | main | JP Morgan | 2 | 8 | 6 | 2 | 2 |
| 2025-03-20 | CAPR | Overweight | Overweight | reit | Cantor Fitzgerald | 3 | 4 | 0 | 0 | 0 |
| 2025-03-20 | CAPR | Buy | Buy | reit | HC Wainwright & Co. | 3 | 4 | 0 | 0 | 0 |
| 2025-03-20 | CAVA | Overweight | Neutral | up | JP Morgan | 2 | 7 | 7 | 0 | 0 |
| 2025-03-20 | CI | Overweight | Overweight | main | Cantor Fitzgerald | 6 | 13 | 6 | 0 | 0 |
| 2025-03-20 | CMG | Neutral | Neutral | main | JP Morgan | 4 | 22 | 9 | 0 | 0 |
| 2025-03-20 | CNP | Equal-Weight | Equal-Weight | main | Morgan Stanley | 1 | 4 | 11 | 0 | 2 |
| 2025-03-20 | COST | Buy | Buy | main | Stifel | 6 | 18 | 14 | 1 | 0 |
| 2025-03-20 | COTY | Buy | Neutral | up | Citigroup | 4 | 9 | 7 | 0 | 1 |
| 2025-03-20 | CVNA | Overweight | Neutral | up | Piper Sandler | 6 | 6 | 11 | 1 | 0 |
| 2025-03-20 | CWH | Overweight | Overweight | main | Keybanc | 3 | 8 | 2 | 0 | 0 |
| 2025-03-20 | D | Equal-Weight | Equal-Weight | main | Morgan Stanley | 1 | 2 | 16 | 0 | 0 |
| 2025-03-20 | DGX | Outperform | Outperform | main | Baird | 1 | 7 | 10 | 0 | 0 |
| 2025-03-20 | DLR | Underweight | Underweight | main | Barclays | 7 | 12 | 7 | 0 | 1 |
| 2025-03-20 | DRI | Equal-Weight | Equal-Weight | reit | Stephens & Co. | 4 | 14 | 10 | 2 | 0 |
| 2025-03-20 | DTE | Overweight | Overweight | main | Morgan Stanley | 2 | 9 | 8 | 0 | 1 |
| 2025-03-20 | DUK | Equal-Weight | Equal-Weight | main | Morgan Stanley | 2 | 7 | 11 | 0 | 0 |
| 2025-03-20 | ED | Underweight | Underweight | main | Morgan Stanley | 0 | 3 | 10 | 1 | 4 |
| 2025-03-20 | EIX | Underweight | Underweight | main | Morgan Stanley | 2 | 11 | 4 | 1 | 0 |
| 2025-03-20 | ESPR | Buy | Buy | reit | HC Wainwright & Co. | 3 | 3 | 2 | 0 | 1 |
| 2025-03-20 | ETR | Equal-Weight | Equal-Weight | main | Morgan Stanley | 3 | 9 | 7 | 1 | 0 |
| 2025-03-20 | EXC | Equal-Weight | Equal-Weight | main | Morgan Stanley | 2 | 6 | 9 | 0 | 2 |
| 2025-03-20 | F | Neutral | Neutral | main | Piper Sandler | 3 | 3 | 16 | 4 | 0 |
| 2025-03-20 | FCX | Overweight | Neutral | up | JP Morgan | 5 | 7 | 8 | 1 | 0 |
| 2025-03-20 | FE | Overweight | Overweight | main | Morgan Stanley | 4 | 4 | 9 | 0 | 1 |
| 2025-03-20 | FIVE | Neutral | Neutral | main | Mizuho | 2 | 6 | 13 | 0 | 2 |
| 2025-03-20 | FIVE | Buy | Buy | main | UBS | 2 | 6 | 13 | 0 | 2 |
| 2025-03-20 | FIVE | Equal-Weight | Equal-Weight | main | Barclays | 2 | 6 | 13 | 0 | 2 |
| 2025-03-20 | FIVE | Hold | Hold | main | Truist Securities | 2 | 6 | 13 | 0 | 2 |
| 2025-03-20 | FIVE | Underperform | Underperform | main | B of A Securities | 2 | 6 | 13 | 0 | 2 |
| 2025-03-20 | FIVE | Equal-Weight | Equal-Weight | main | Morgan Stanley | 2 | 6 | 13 | 0 | 2 |
| 2025-03-20 | FIVN | Buy | Buy | main | Rosenblatt | 5 | 12 | 5 | 0 | 0 |
| 2025-03-20 | GIS | Neutral | Neutral | main | Mizuho | 3 | 2 | 16 | 0 | 0 |
| 2025-03-20 | GIS | Neutral | Neutral | main | JP Morgan | 3 | 2 | 16 | 0 | 0 |
| 2025-03-20 | GIS | Buy | Buy | main | B of A Securities | 3 | 2 | 16 | 0 | 0 |
| 2025-03-20 | GM | Neutral | Neutral | main | Piper Sandler | 6 | 12 | 9 | 1 | 1 |
| 2025-03-20 | IMVT | Buy | Buy | reit | Guggenheim | 3 | 10 | 2 | 0 | 0 |
| 2025-03-20 | IMVT | Buy | Buy | main | B of A Securities | 3 | 10 | 2 | 0 | 0 |
| 2025-03-20 | INSM | Buy | Buy | main | B of A Securities | 6 | 12 | 0 | 0 | 0 |
| 2025-03-20 | IP | Overweight | init | JP Morgan | 2 | 5 | 5 | 0 | 1 | |
| 2025-03-20 | IRM | Overweight | Overweight | main | Barclays | 5 | 1 | 0 | 1 | 0 |
| 2025-03-20 | KKR | Overweight | Equal-Weight | up | Wells Fargo | 6 | 11 | 3 | 0 | 0 |
| 2025-03-20 | LUV | Neutral | Sell | up | UBS | 2 | 3 | 12 | 2 | 4 |
| 2025-03-20 | LUV | Hold | Sell | up | Melius Research | 2 | 3 | 12 | 2 | 4 |
| 2025-03-20 | MOS | Outperform | Perform | up | Oppenheimer | 6 | 5 | 9 | 0 | 1 |
| 2025-03-20 | MP | Market Perform | Market Perform | main | BMO Capital | 0 | 8 | 4 | 0 | 0 |
| 2025-03-20 | MSFT | Buy | Buy | main | Tigress Financial | 14 | 38 | 4 | 0 | 0 |
| 2025-03-20 | MSFT | Outperform | Outperform | reit | Wedbush | 14 | 38 | 4 | 0 | 0 |
| 2025-03-20 | MSFT | Sector Outperform | init | Scotiabank | 14 | 38 | 4 | 0 | 0 | |
| 2025-03-20 | NCNO | Equal-Weight | Equal-Weight | reit | Stephens & Co. | 7 | 4 | 5 | 0 | 0 |
| 2025-03-20 | NEE | Overweight | Overweight | main | Morgan Stanley | 6 | 8 | 8 | 1 | 0 |
| 2025-03-20 | NEE | Buy | Buy | reit | Guggenheim | 6 | 8 | 8 | 1 | 0 |
| 2025-03-20 | NVDA | Neutral | Neutral | main | DA Davidson | 11 | 46 | 5 | 0 | 0 |
| 2025-03-20 | NVDA | Buy | Buy | reit | Benchmark | 11 | 46 | 5 | 0 | 0 |
| 2025-03-20 | OLLI | Overweight | Overweight | main | Piper Sandler | 4 | 7 | 4 | 0 | 0 |
| 2025-03-20 | OLLI | Neutral | Neutral | main | UBS | 4 | 7 | 4 | 0 | 0 |
| 2025-03-20 | OLLI | Equal-Weight | Equal-Weight | main | Morgan Stanley | 4 | 7 | 4 | 0 | 0 |
| 2025-03-20 | OMC | Buy | Buy | main | UBS | 5 | 3 | 2 | 0 | 1 |
| 2025-03-20 | PCG | Underweight | Underweight | main | Morgan Stanley | 5 | 7 | 6 | 1 | 0 |
| 2025-03-20 | PEG | Overweight | Overweight | main | Morgan Stanley | 2 | 7 | 10 | 0 | 2 |
| 2025-03-20 | PGEN | Market Outperform | Market Outperform | reit | Citizens Capital Markets | 2 | 2 | 0 | 0 | 1 |
| 2025-03-20 | PGEN | Buy | Buy | reit | HC Wainwright & Co. | 2 | 2 | 0 | 0 | 1 |
| 2025-03-20 | PGR | Outperform | Outperform | main | Keefe, Bruyette & Woods | 8 | 3 | 6 | 1 | 0 |
| 2025-03-20 | PGR | Buy | Buy | main | B of A Securities | 8 | 3 | 6 | 1 | 0 |
| 2025-03-20 | PII | Sell | Neutral | down | Citigroup | 0 | 4 | 12 | 1 | 1 |
| 2025-03-20 | PNW | Equal-Weight | Equal-Weight | main | Morgan Stanley | 0 | 8 | 8 | 0 | 1 |
| 2025-03-20 | PPL | Overweight | Overweight | main | Morgan Stanley | 4 | 8 | 4 | 0 | 1 |
| 2025-03-20 | RDDT | Buy | Buy | main | Guggenheim | 5 | 8 | 7 | 1 | 1 |
| 2025-03-20 | RGNX | Buy | Buy | reit | HC Wainwright & Co. | 5 | 6 | 1 | 0 | 0 |
| 2025-03-20 | RGNX | Buy | Buy | main | Chardan Capital | 5 | 6 | 1 | 0 | 0 |
| 2025-03-20 | RIVN | Neutral | Overweight | down | Piper Sandler | 2 | 7 | 17 | 0 | 3 |
| 2025-03-20 | SHAK | Underweight | Underweight | main | JP Morgan | 2 | 9 | 11 | 0 | 1 |
| 2025-03-20 | SNDX | Overweight | Overweight | main | JP Morgan | 4 | 10 | 1 | 0 | 0 |
| 2025-03-20 | SO | Equal-Weight | Equal-Weight | main | Morgan Stanley | 3 | 4 | 12 | 1 | 1 |
| 2025-03-20 | SRE | Overweight | Overweight | main | Morgan Stanley | 3 | 7 | 9 | 0 | 0 |
| 2025-03-20 | SRPT | Sector Perform | Sector Perform | main | Scotiabank | 9 | 12 | 2 | 1 | 0 |
| 2025-03-20 | STZ | Neutral | Buy | down | Citigroup | 7 | 8 | 11 | 0 | 0 |
| 2025-03-20 | TGT | Hold | Hold | main | Stifel | 4 | 11 | 21 | 0 | 1 |
| 2025-03-20 | TSLA | Outperform | Outperform | reit | Wedbush | 7 | 16 | 14 | 9 | 2 |
| 2025-03-20 | TSLA | Overweight | Overweight | main | Piper Sandler | 7 | 16 | 14 | 9 | 2 |
| 2025-03-20 | TXRH | Neutral | Neutral | main | JP Morgan | 1 | 11 | 17 | 0 | 0 |
| 2025-03-20 | UAL | Buy | Buy | main | UBS | 8 | 15 | 0 | 1 | 0 |
| 2025-03-20 | ULCC | Neutral | Neutral | main | UBS | 1 | 0 | 10 | 0 | 1 |
| 2025-03-20 | VEEV | Neutral | Neutral | main | JP Morgan | 7 | 13 | 10 | 1 | 1 |
| 2025-03-20 | VERX | Market Outperform | Market Outperform | reit | Citizens Capital Markets | 4 | 4 | 5 | 0 | 0 |
| 2025-03-20 | VERX | Overweight | Overweight | main | Morgan Stanley | 4 | 4 | 5 | 0 | 0 |
| 2025-03-20 | VERX | Buy | Buy | reit | Needham | 4 | 4 | 5 | 0 | 0 |
| 2025-03-20 | VSTS | Neutral | Neutral | main | Baird | 0 | 2 | 6 | 0 | 1 |
| 2025-03-20 | WMT | Hold | Hold | main | Stifel | 12 | 25 | 4 | 1 | 0 |
| 2025-03-20 | WSM | Buy | Buy | main | Jefferies | 1 | 4 | 18 | 0 | 2 |
| 2025-03-20 | WSM | Neutral | Neutral | main | Wedbush | 1 | 4 | 18 | 0 | 2 |
| 2025-03-20 | WSM | Neutral | Neutral | main | JP Morgan | 1 | 4 | 18 | 0 | 2 |
| 2025-03-20 | WSM | Neutral | Sell | up | UBS | 1 | 4 | 18 | 0 | 2 |
| 2025-03-20 | WSM | Equal-Weight | Equal-Weight | main | Morgan Stanley | 1 | 4 | 18 | 0 | 2 |
| 2025-03-20 | WSM | Outperform | Outperform | main | Telsey Advisory Group | 1 | 4 | 18 | 0 | 2 |
| 2025-03-20 | XEL | Equal-Weight | Equal-Weight | main | Morgan Stanley | 3 | 9 | 4 | 0 | 1 |
| 2025-03-20 | YUM | Neutral | Neutral | main | JP Morgan | 2 | 5 | 21 | 0 | 1 |